Rashad Mumtaz Khan, M.D.
Hematology & Oncology Physician · Longview, TX
Rashad Mumtaz Khan, M.D. is a hematology & oncology physician with a practice address in Longview, Texas, and NPI 1235516725, issued on May 4, 2015. Check the license (Texas T1414, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Rashad Mumtaz Khan
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- T1414 TX
Self-reported in NPPES; status is on the state search - Practice location
- 1400 N 4TH St, Longview, TX 75601
- Phone
- (903) 757-2122
- Enumerated
- May 4, 2015
- Record last updated
- Aug 29, 2022
- Fax
- (903) 757-9475
- Medicare enrollment
- Enrolled (PECOS I20210818001143); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 922 in Texas → Look up another NPI →
Also registered at 1400 N 4TH St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Devin Brecheen, PAPhysician Assistant1447534854
- Matei Socoteanu, M.D.Medical Oncology Physician1629269774
- Christi WilliamsAcute Care Nurse Practitioner1215581905
Verify Rashad Mumtaz Khan in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license T1414Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
28% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
628 Medicare Part D claims for 121 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 12% of claims. 68 claims were for opioids.
Most prescribed
- Letrozole55 claims
- Acyclovir45 claims
- Hydrocodone-Acetaminophen39 claims
- Prednisone39 claims
- Dexamethasone33 claims
- Ondansetron Hcl25 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $2,984.61
46 payments; by number, the most common kind was food and beverage; the largest payer was Novartis Pharmaceuticals Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Texas Oncology PALongview, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Rashad Mumtaz Khan among 922 hematology & oncology physician records in Texas
Rashad Mumtaz Khan, M.D. is one of 922 hematology & oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2015, is newer than 80% of them.
- NPI issued2015 · 80% of these records are older, 16% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2015 · median 2004 among the 691 with a school on file
- Record last updated2022 · 51% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
All 922 in Texas → Every provider in Longview → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Rama Koya, MDLongview, TX 756011407895832
- Christopher Littlejohn, M.D.Longview, TX 756011952764318
- Margaret Schottstaedt, MDLongview, TX 756041407999154
- Adewunmi FalohunLongview, TX 756051427687219
- Mindie Kavanaugh, MDLongview, TX 756051487897922
- Kavita Nirmal, M.D.Marshall, TX 756701760619621
- Edward Eichler, MDTexarkana, TX 755031801869235
- Gary Engstrom, MDTexarkana, TX 755031336149731
Common questions
What is Rashad Mumtaz Khan, M.D.'s NPI number?
Rashad Mumtaz Khan, M.D.'s National Provider Identifier (NPI) is 1235516725, issued on May 4, 2015. An NPI identifies a provider in billing; it is not a license.
Where is Rashad Mumtaz Khan, M.D. located?
The NPPES record lists a practice address at 1400 N 4TH St, Longview, TX, 75601. Phone: (903) 757-2122. Providers update this record themselves, so call before visiting.
How can I verify Rashad Mumtaz Khan, M.D.'s license?
NPPES lists Texas license number T1414, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Rashad Mumtaz Khan, M.D. prescribe under Medicare Part D?
In 2024, Rashad Mumtaz Khan, M.D. had 628 Medicare Part D claims for 121 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.